This inventor holds 38 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 21 EPO patents, primarily in Estrogen Receptor Modulators. Top assignees: Corcept Therapeutics Incorporated, Chiesi Farmaceutici S.p.a., Genentech, Inc.. Active years: 2010-2025.
Location History:
- Flex Meadow, GB (2014)
- Harlow Essex, GB (2016 - 2020)
- Harlow, GB (2010 - 2021)
- Essex, GB (2010 - 2023)
Company Filing History:
16 out of 138 
9 out of 340 
9 out of 3,292 
Years Active: 2010-2025
Areas of Expertise:
Title: The Innovative Journey of Nicholas Charles Ray in Patent Development
Introduction: Nicholas Charles Ray is a prominent inventor based in Harlow, GB, recognized for his contributions to the field with 38 patents to his name. His innovative work has significantly impacted various areas of research and development, particularly within the pharmaceutical industry.
Latest Patents: Among his latest patents, two noteworthy inventions stand out. The first is titled "Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof." This invention describes tetrahydro-pyrido[3,4-b]indol-1-yl compounds that possess estrogen receptor modulation activity or function. The second is the "Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators." This patent provides novel heteroaryl ketone fused azadecalin compounds and outlines methods for their use as glucocorticoid receptor modulators, including their potential application in treating amyotrophic lateral sclerosis (ALS).
Career Highlights: Nicholas has made remarkable contributions throughout his career, which include his tenure at leading companies such as Corcept Therapeutics Incorporated and Genentech, Inc. His innovative spirit and dedication to advancing science have positioned him as a key figure within these organizations.
Collaborations: Working alongside talented individuals has been a significant part of Nicholas's career. Notable collaborators include Christopher Hurley and Hazel Joan Hunt, with whom he has shared insights and expertise in his research endeavors.
Conclusion: Nicholas Charles Ray's continued commitment to innovation is exemplified through his extensive portfolio of patents and collaborative efforts with esteemed colleagues. His work not only underscores the importance of research and development in the pharmaceutical industry but also highlights the potential for innovative solutions to improve healthcare outcomes.